Elsevier, the leading publisher of scientific, technical and medical information, is pleased to announce its renewed publishing partnership with The European Association for the Study of the Liver (EASL), the leading European association in the field of liver research. The agreement calls for Elsevier to publish the society's flagship journal, the Journal of Hepatology, for the next five years.

EASL is a society with over 1500 members. The society has given rise to a significant number of international clinical trials and research collaborations in liver disease for the benefit of patients all over the world. EASL's flagship journal - the Journal of Hepatology - requires high standard quality contents and is highly perceived in its field. The journal publishes original papers, reviews, case reports and letters to the editor concerned with clinical and basic research in the field of hepatology.

"I am thankful to work with a professional learned society and also very grateful for its support and input over the last years. I look forward to working with the newly appointed Editor-in-Chief, Professor Didier Samuel and his editorial team. The management and cure of, for instance, infectious liver diseases like Hepatitis B and C as well as the advanced search for the basic mechanisms of liver failure are major and global challenges of the 21st century. Elsevier is confident to make the Journal of Hepatology a continuing and growing success for authors, readers and for EASL" commented Koos Admiraal MD, Publisher for Elsevier.

Source:
Koos Admiraal
Elsevier